This news is delayed by 15 minutes, sign up now to get live news & full features.
VINC VINCERX PHARMA INC
+ add to watchlist
$0.06
vincerx is a clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer.
Mkt Cap: $41.61M
52 Week High: $10.37
P/E: 0.00
52 Week Low: $0.08
Dividend: $0.00
Shares Outstanding: 5.23M